Tolerability of adjuvant chemotherapy with S-1 after curative resection in patients with stage II/III gastric cancer

The results of the Japan Clinical Oncology Group trial demonstrated that adjuvant chemotherapy with S-1 for stage II/III gastric cancer is effective and suggested that this therapy should be adopted as the standard treatment following curative D2 gastric dissection. We reviewed treatment outcomes in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: TSUJIMOTO, HIRONORI, HORIGUCHI, HIROYUKI, HIRAKI, SHUICHI, YAGUCHI, YOSHIHISA, TAKAHATA, RISA, KUMANO, ISAO, YOSHIDA, KAZUMICHI, MATSUMOTO, YUSUKE, ONO, SATOSHI, YAMAMOTO, JUNJI, HASE, KAZUO
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2012
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3499559/
https://ncbi.nlm.nih.gov/pubmed/23162667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2012.882
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller